Clinical Trials Browser

Withdrawn × Breast Neoplasms × Abiraterone Acetate × Clear all

NCT01814865 2013-12-20

Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms